b -Amyloid impairs the regulation of N -methyl-D-aspartate receptors by glycogen synthase kinase 3 Neurobiology of Aging

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Microdose lithium treatment stabilized cognitive impairment in patients with Alzheimer's disease.

  2013cited by this paper
• Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes.

  2013cited by this paper
• Repeated stress causes cognitive impairment by suppressing glutamate receptor expression and function in prefrontal cortex.

  2012cited by this paper
• Vascular neuroprotection via TrkB‐ and Akt‐dependent cell survival signaling

  2012cited by this paper
• Activation of glycogen synthase kinase-3 beta mediates β-amyloid induced neuritic damage in Alzheimer's disease.

  2012influential reference
• Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-b

  2012cited by this paper
• Agrin regulates CLASP2-mediated capture of microtubules at the neuromuscular junction synaptic membrane

  2012cited by this paper
• Dynamic association of tau with neuronal membranes is regulated by phosphorylation.

  2012cited by this paper
• Synergistic interactions between PDE4B and GSK-3: DISC1 mutant mice.

  2012cited by this paper
• RACK 1 is involved in-amyloid impairment of muscarinic regulation of GABAergic transmission

  2011cited by this paper
• Involvement of the Glycogen Synthase Kinase-3 Signaling Pathway in TBI Pathology and Neurocognitive Outcome

  2011cited by this paper
• Pathogenic protein seeding in alzheimer disease and other neurodegenerative disorders

  2011cited by this paper
• Amyloid β peptide oligomers directly activate NMDA receptors.

  2011cited by this paper
• GSK3: a possible link between beta amyloid peptide and tau protein.

  2010cited by this paper
• Regulation of AMPA Receptor Trafficking and Function by Glycogen Synthase Kinase 3 *

  2010cited by this paper
• Regulation of AMPA Receptor Trafficking and Function by Glycogen Synthase Kinase 3*

  2010cited by this paper
• GSK3 signalling in neural development

  2010cited by this paper
• A novel GSK-3beta inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo.

  2009cited by this paper
• β-Amyloid Impairs AMPA Receptor Trafficking and Function by Reducing Ca2+/Calmodulin-dependent Protein Kinase II Synaptic Distribution*

  2009cited by this paper
• Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model

  2007cited by this paper
• Glycogen synthase kinase‐3 inhibition is integral to long‐term potentiation

  2007cited by this paper
• LTP inhibits LTD in the hippocampus via regulation of GSK3beta.

  2007cited by this paper
• Glycogen Synthase Kinase 3 Regulates N-Methyl-d-aspartate Receptor Channel Trafficking and Function in Cortical Neurons

  2007cited by this paper
• Glycogen Synthase Kinase-3 (GSK3): Inflammation, Diseases, and Therapeutics

  2007influential reference
• Activation of Glycogen Synthase Kinase-3 Inhibits Long-Term Potentiation with Synapse-Associated Impairments

  2007cited by this paper
• N-terminal Cleavage of GSK-3 by Calpain

  2007cited by this paper
• Degradation of the Alzheimer Disease Amyloid β-Peptide by Metal-dependent Up-regulation of Metalloprotease Activity*

  2006cited by this paper
• Non‐fibrillar β‐amyloid abates spike‐timing‐dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors

  2006influential reference
• Age-related changes in glycogen synthase kinase 3beta (GSK3beta) immunoreactivity in the central nervous system of rats.

  2006cited by this paper
• NMDA receptor-dependent activation of the small GTPase Rab5 drives the removal of synaptic AMPA receptors during hippocampal LTD.

  2005cited by this paper
• Alzheimer's disease: Abeta, tau and synaptic dysfunction.

  2005cited by this paper
• Regulation of NMDA receptor trafficking by amyloid-beta.

  2005cited by this paper
• Serotonin 5-HT1A Receptors Regulate NMDA Receptor Channels through a Microtubule-Dependent Mechanism

  2005cited by this paper
• Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses.

  2005cited by this paper
• Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo.

  2005cited by this paper
• Pharmacological inhibitors of glycogen synthase kinase 3.

  2004cited by this paper
• Regulation of NMDA Receptors by Dopamine D4 Signaling in Prefrontal Cortex

  2003cited by this paper
• Dendritic spine loss in the hippocampus of young PDAPP and Tg2576 mice and its prevention by the ApoE2 genotype.

  2003cited by this paper
• GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides.

  2003influential reference
• Oligomeric and Fibrillar Species of Amyloid-β Peptides Differentially Affect Neuronal Viability*

  2002influential reference
• Glutamate receptor dysregulation in the hippocampus of transgenic mice carrying mutated human amyloid precursor protein.

  2001cited by this paper
• A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation.

  2001cited by this paper
• GSK3 takes centre stage more than 20 years after its discovery.

  2001cited by this paper
• CA1-specific N-methyl-d-aspartate receptor knockout mice are deficient in solving a nonspatial transverse patterning task

  2001cited by this paper
• Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice.

  2001cited by this paper
• Selective small‐molecule inhibitors of glycogen synthase kinase‐3 activity protect primary neurones from death

  2001cited by this paper
• Three rat brain alternative splicing dynamin-like protein variants: interaction with the glycogen synthase kinase 3beta and action as a substrate.

  2000cited by this paper
• Role of Glycogen Synthase Kinase-3 in the Phosphatidylinositol 3-Kinase/Akt Cell Survival Pathway*

  1998cited by this paper
• Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging.

  1998cited by this paper
• Distinct Rab‐binding domains mediate the interaction of Rabaptin‐5 with GTP‐bound rab4 and rab5

  1998cited by this paper
• Overexpression of Tau Protein Inhibits Kinesin-dependent Trafficking of Vesicles, Mitochondria, and Endoplasmic Reticulum: Implications for Alzheimer's Disease

  1998cited by this paper
• Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau.

  1997cited by this paper
• Cellular phosphorylation of tau by GSK-3 beta influences tau binding to microtubules and microtubule organisation.

  1996cited by this paper
• GSK3: a SHAGGY frog story.

  1996cited by this paper
• Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

  1996influential reference
• Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

  1995cited by this paper
• Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures.

  1995cited by this paper
• Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function.

  1995cited by this paper
• Memories of NMDA receptors and LTP

  1995cited by this paper
• The small GTPase rab5 functions as a regulatory factor in the early endocytic pathway.

  1992cited by this paper
• Tau protein function in living cells

  1986cited by this paper
• Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.

  1986cited by this paper
• Amyloid plaque core protein in Alzheimer disease and Down syndrome.

  1985cited by this paper
• Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase.

  1980cited by this paper
• Neurobiology of Disease Soluble ␤-amyloid 1– 40 Induces Nmda-dependent Degradation of Postsynaptic Density-95 at Glutamatergic Synapses

  year unknowncited by this paper

• Altered synaptic currents, mitophagy, mitochondrial dynamics in Alzheimer's disease models and therapeutic potential of Dengzhan Shengmai capsules intervention

  2023cites this paper
• Metabotropic glutamate receptors: the potential for therapeutic applications in Alzheimer's disease

  2018cites this paper
• Linking Traumatic Brain Injury to Chronic Traumatic Encephalopathy: Identification of Potential Mechanisms Leading to Neurofibrillary Tangle Development

  2014cites this paper